PXT002331
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PXT002331, covering 2020-03-17 to 2020-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients [Phase 2]